Back to search

Aventis Pharma ltd t/a Sanofi

27 contracts won£6,802,312,331 total value

Every public sector contract Aventis Pharma ltd t/a Sanofi has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Aventis Pharma ltd t/a Sanofi for you, and alerts you the moment a renewal goes live.

Where they win

The sectors, tender types and buyers where Aventis Pharma ltd t/a Sanofi wins most often.

See every live NHS tenders and find your next contract before they do.

See all NHS buyers and UK contract awards.

Sectors

Healthcare & Medical27

Top Buyers

NHS England
15 contracts
£6,269,200,396
The NHS Commissioning Board (operating under the name of NHS England)
3 contracts
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
2 contracts
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
1 contract
£16,000
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
1 contract
£263,956
The Department for Business, Energy and Industrial Strategy (BEIS)
1 contract
Atamis LTD
1 contract
£428,226,984
UK Health Security Agency
1 contract

Awards(27)

Sort:

Gastrointestinal, Endocrine, Nutrition & Blood Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Edinburgh
£263,956
Awarded 1 Jul 2025

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS England
Runcorn
£261,895,933
Awarded 25 Jun 2025
Ends 31 Aug 2027

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS England
Runcorn
£1,241,520,444
Awarded 24 Mar 2025
Ends 30 Apr 2029

Td/IPV (2025)

UK Health Security Agency
London
Not specified
Awarded 19 Mar 2025
Ends 30 Sept 2030

Td/IPV (2025)

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
London
Not specified
Awarded 19 Mar 2025
Ends 30 Sept 2030

NHS Branded Medicines Tranche Framework for London and South of England

NHS England
Runcorn
£380,950,720
Awarded 22 Jul 2024
Ends 31 Aug 2026

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS England
Runcorn
£1,009,500,000
Awarded 5 Apr 2024
Ends 30 Apr 2028

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS England
Runcorn
£688,010,000
Awarded 26 Jan 2024
Ends 31 Aug 2026

NHS South of England Branded Medicines - Tranche A - September 2023

NHS England
Runcorn
£249,832,000
Awarded 18 Jul 2023
Ends 31 Aug 2025

CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins

NHS England
Runcorn
£186,609,000
Awarded 14 Jul 2023
Ends 31 Aug 2025

NHS London Branded Medicines - Tranche B - September 2023

NHS England
Runcorn
£231,083,000
Awarded 14 Jul 2023
Ends 31 Aug 2025

NHS National Generic Pharmaceuticals Wave 14b

Atamis LTD
Runcorn
£428,226,984
Awarded 7 Jul 2023
Ends 30 Sept 2025

DTaP/IPV 2024

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
London
Not specified
Awarded 22 Jun 2023

NHS National Generics Pharmaceuticals Transition 2023_1

NHS england
Runcorn
£57,604,995
Awarded 5 May 2023
Ends 31 Jan 2025

NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals

NHS England
Runcorn
£304,504,000
Awarded 24 Apr 2023
Ends 30 Apr 2025

NHS Midland & East Branded Medicines, Tranche B & Annual Tranche

NHS England
Runcorn
£480,429,000
Awarded 13 Feb 2023
Ends 28 Feb 2025

NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche

NHS England
RUNCORN
£261,970,000
Awarded 8 Feb 2023
Ends 28 Feb 2025

NHS National Generic Pharmaceuticals Wave 14a

NHS England
East Midlands
£207,982,407
Awarded 14 Dec 2022
Ends 31 Jan 2025

NHS Framework Agreement for Branded Medicines - National Tender

NHS England
Leeds
Not specified
Awarded 16 May 2022

NHS Framework Agreement for Branded medicines - National

NHS England
Runcorn
£526,000,000
Awarded 16 May 2022
Ends 30 Apr 2024

Know when Aventis Pharma ltd t/a Sanofi's contracts come up for renewal

Business predicts when each of these contracts is due to be re-tendered, follows Aventis Pharma ltd t/a Sanofi for you, and alerts you the moment a renewal goes live, so you can bid before the incumbent locks it in again.

Page 1 of 2

Why track Aventis Pharma ltd t/a Sanofi?

Aventis Pharma ltd t/a Sanofi is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.

How renewal tracking works

We aggregate Aventis Pharma ltd t/a Sanofi's award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.

What you can do here

  • Review the full history. Every contract Aventis Pharma ltd t/a Sanofi has won, with the buyer, value and dates for each.
  • Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
  • Track and get alerted. Follow Aventis Pharma ltd t/a Sanofi and be notified when their contracts come up again (Business).
  • Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.

Frequently asked questions

Where does this data come from?

Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.

Is the contract history free?

Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.

How do you predict renewals?

From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.